Sphera Funds Management Ltd. Obs Eva Sa Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$10.8 - $17.94 $2.63 Million - $4.37 Million	-243,669 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$10.0 - $17.87 $5.02 Million - $8.96 Million	-501,528 Reduced 67.3%	243,669 $3.69 Million
Q1 2018 May 10, 2018	BUY	$9.36 - $15.22 $1.85 Million - $3.01 Million	197,500 Added 36.06%	745,197 $10.1 Million
Q4 2017 Feb 12, 2018	BUY	$8.48 - $12.0 $2.44 Million - $3.45 Million	287,500 Added 110.49%	547,697 $5.35 Million
Q3 2017 Nov 09, 2017	BUY	$6.38 - $8.14 $1.66 Million - $2.12 Million	260,197	260,197 $2.12 Million

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.